Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,434.78
(
-0.89%
)
US TECH 100
28,467.20
(
-1.13%
)
Dow Jones
49,625.91
(
-0.87%
)
Brent Oil
106.41
(
2.14%
)
Bitcoin
79,301.72
(
-2.17%
)
News Focus
News Focus
Post# of 257575
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122986
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 215049

Monday, 12/18/2017 11:26:13 AM

Monday, December 18, 2017 11:26:13 AM

Post# of 257575
NVS buys PRV for $130M from RARE—RTH258 likely beneficiary (IMO):

https://finance.yahoo.com/news/ultragenyx-sells-priority-review-voucher-133000076.html

See #msg-136129447 for phase-3 data on RTH258 (a/k/a brolucizumab).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today